Search research articles
Contact Us
Filters
Showing results (71-80 of 480) with videos related to
Page
of 48
Sort By:
Journal of Medicinal Chemistry
|
July 16, 2020
New Horizons in Drug Discovery - Understanding and Advancing Kinase Inhibitors
Stefan Laufer, Karin Briner, Jürgen Bajorath, et al.
Journal of Medicinal Chemistry
|
May 22, 2020
Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein
Mingliang Wang, Jianfeng Lu, Mi Wang, et al.
Advances in Experimental Medicine and Biology
|
January 4, 2020
Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway
Haibin Zhou, Jianfeng Lu, Chao-Yie Yang, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 12, 2006
Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein
Jianyong Chen, Zaneta Nikolovska-Coleska, Guoping Wang, et al.
Anticancer Research
|
December 29, 2010
Expression of anti-apoptosis genes determines the response of adrenal cancer to apoptosis-inducing chemotherapy
David E Schteingart, Ricardo Benitez, Carol Bradford, et al.
Molecular Cancer Therapeutics
|
October 22, 2016
Reactivation of p53 by MDM2 Inhibitor MI-77301 for the Treatment of Endocrine-Resistant Breast Cancer
Jianfeng Lu, Donna McEachern, Shunqiang Li, et al.
Neoplasia (New York, N.Y.)
|
April 24, 2022
Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-X<sub>L</sub> dual inhibitor that induces Bax-dependent apoptosis
Weilong Yao, Longchuan Bai, Shaomeng Wang, et al.
Journal of Medicinal Chemistry
|
June 26, 2010
Analysis of the binding of mixed lineage leukemia 1 (MLL1) and histone 3 peptides to WD repeat domain 5 (WDR5) for the design of inhibitors of the MLL1-WDR5 interaction
Hacer Karatas, Elizabeth C Townsend, Denzil Bernard, et al.
Journal of Medicinal Chemistry
|
June 10, 2005
The PDBbind database: methodologies and updates
Renxiao Wang, Xueliang Fang, Yipin Lu, et al.
Cancer Biology & Therapy
|
March 15, 2008
A small molecule that disrupts Mdm2-p53 binding activates p53, induces apoptosis and sensitizes lung cancer cells to chemotherapy
Steven H Sun, Min Zheng, Ke Ding, et al.
Page
of 48
Search research articles
Search
Showing results (71-80 of 480) with videos related to
Sort By:
Page
of 48
Journal of Medicinal Chemistry
|
July 16, 2020
New Horizons in Drug Discovery - Understanding and Advancing Kinase Inhibitors
Stefan Laufer, Karin Briner, Jürgen Bajorath, et al.
Journal of Medicinal Chemistry
|
May 22, 2020
Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein
Mingliang Wang, Jianfeng Lu, Mi Wang, et al.
Advances in Experimental Medicine and Biology
|
January 4, 2020
Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway
Haibin Zhou, Jianfeng Lu, Chao-Yie Yang, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 12, 2006
Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein
Jianyong Chen, Zaneta Nikolovska-Coleska, Guoping Wang, et al.
Anticancer Research
|
December 29, 2010
Expression of anti-apoptosis genes determines the response of adrenal cancer to apoptosis-inducing chemotherapy
David E Schteingart, Ricardo Benitez, Carol Bradford, et al.
Molecular Cancer Therapeutics
|
October 22, 2016
Reactivation of p53 by MDM2 Inhibitor MI-77301 for the Treatment of Endocrine-Resistant Breast Cancer
Jianfeng Lu, Donna McEachern, Shunqiang Li, et al.
Neoplasia (New York, N.Y.)
|
April 24, 2022
Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-X<sub>L</sub> dual inhibitor that induces Bax-dependent apoptosis
Weilong Yao, Longchuan Bai, Shaomeng Wang, et al.
Journal of Medicinal Chemistry
|
June 26, 2010
Analysis of the binding of mixed lineage leukemia 1 (MLL1) and histone 3 peptides to WD repeat domain 5 (WDR5) for the design of inhibitors of the MLL1-WDR5 interaction
Hacer Karatas, Elizabeth C Townsend, Denzil Bernard, et al.
Journal of Medicinal Chemistry
|
June 10, 2005
The PDBbind database: methodologies and updates
Renxiao Wang, Xueliang Fang, Yipin Lu, et al.
Cancer Biology & Therapy
|
March 15, 2008
A small molecule that disrupts Mdm2-p53 binding activates p53, induces apoptosis and sensitizes lung cancer cells to chemotherapy
Steven H Sun, Min Zheng, Ke Ding, et al.
Page
of 48